Android Apple

Outlook Therapeutics, Inc.'s (NASDAQ:OTLK) largest shareholders are individual investors with 31% ownership, private equity firms own 31%

By Yahoo! Finance   |   6 months ago
Outlook Therapeutics, Inc.'s (NASDAQ:OTLK) largest shareholders are individual investors with 31% ownership, private equity firms own 31%

Outlook Therapeutics has 6 main investors holding a majority stake, with individual investors and private equity firms each owning 31%. The top 6 shareholders control over half of the company's shares, suggesting a balanced mix of interests.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.